4.8 Review

A Call for Systematic Research on Solute Carriers

期刊

CELL
卷 162, 期 3, 页码 478-487

出版社

CELL PRESS
DOI: 10.1016/j.cell.2015.07.022

关键词

-

资金

  1. Austrian Academy of Sciences
  2. ERC [250179]
  3. Swiss National Science Foundation [P300P3_147897]
  4. Marie Curie Actions International Fellowship Program (IFP) TransCure
  5. Swiss National Center of Competence in Research (NCCR TransCure)
  6. AbbVie
  7. Bayer Pharma AG
  8. Boehringer Ingelheim
  9. Eshelman Institute for Innovation
  10. Genome Canada
  11. Janssen
  12. Merck Co.
  13. Novartis Pharma AG
  14. Ontario Ministry of Economic Development and Innovation
  15. Pfizer
  16. Sao Paulo Research Foundation-FAPESP
  17. Takeda
  18. Wellcome Trust
  19. Swiss National Science Foundation (SNF) [P300P3_147897] Funding Source: Swiss National Science Foundation (SNF)
  20. European Research Council (ERC) [250179] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Solute carrier (SLC) membrane transport proteins control essential physiological functions, including nutrient uptake, ion transport, and waste removal. SLCs interact with several important drugs, and a quarter of the more than 400 SLC genes are associated with human diseases. Yet, compared to other gene families of similar stature, SLCs are relatively understudied. The time is right for a systematic attack on SLC structure, specificity, and function, taking into account kinship and expression, as well as the dependencies that arise from the common metabolic space.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据